Limits and handicaps of the intermittent malaria treatment;Limites et faiblesses du traitement intermittent dans la prévention du paludisme

Bulletin de la Societe de Pathologie Exotique

Volumn 96, Issue 2, 2003, Pages 75-76

  Chippaux, J P ^a   Le Hesran, J Y ^a   Cot, M ^a   Massougbodji, A ^b  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^b UNIVERSITY OF ABOMEY CALAVI   (Benin)

Author keywords

Chloroquine; Control strategy; Malaria; Prophylaxis; Pyrimethamine; Resistance; Sulfadoxine

Indexed keywords

FANSIDAR;

CONTROL STRATEGY; DRUG INTERMITTENT THERAPY; HUMAN; MALARIA; MALARIA CONTROL; PLASMODIUM FALCIPARUM; PROPHYLAXIS; REVIEW; VACCINATION;

ANTIMALARIALS; DRUG THERAPY, COMBINATION; HUMANS; MALARIA; PYRIMETHAMINE; SULFADOXINE; WORLD HEALTH ORGANIZATION;

EID: 0038043197     PISSN: 00379085     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (7)

1. ème conférence de consensus en thérapeutique anti-infectieuse de la Société de pathologie infectieuse de langue française (SPILF). Prise en charge et prévention du paludisme d'importation à Plasmodium falciparum. Méd Mal Inf, 1999, S2, 115s-141s.
2. GREENWOOD BM, DAVID PH, OTOOFORBES LN, ALLEN SJ, ALONSO PL et al. - Mortality and morbidity from malaria after stopping malaria chemoprophylaxis. Trans R Soc Trop Med Hyg, 1995, 89, 629-633.
3. MILLER KD, LOBEL HO, SATRIALE RF, KIRUTSKY JN, STERN & CAMPBELL CC - Severe cutaneous reactions among American travellers using pyrimethamine-sulfadoxine (Fansidar®) for malaria prophylaxis. Am J Trop Med Hyg, 1986, 35, 451-458.
4. OMS - Traitement intermittent du paludisme dans le cadre du calendrier du PEV en Afrique. Rel Epidémiol Hebdo, 2002, 77, 82-83.
5. PHILLIPS-HOWARD PA & BJORKMAN AB - Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs. Bull OMS, 1990, 68, 493-504.
6. SCHELLENBERG D, MENEDEZ C, KAHIGWA E, APONTE J, VIDAL J et al.-Intermittent treatment for malaria and anaemia control at time of routine vacci nations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet, 2001, 357, 1471-1477.
7. WONGSRICHANALAI C, PICKARD AL, WERNSDORFER WH & MESHNICK SR - Epidemiology of drug-resistant malaria. Lancet Infect Dis, 2002, 2, 209-218.